Skip to main content
. Author manuscript; available in PMC: 2023 Jun 14.
Published in final edited form as: Immunity. 2022 Dec 28;56(1):107–124.e5. doi: 10.1016/j.immuni.2022.12.002

Figure 3. Tumor-specific CD8+ T cells activated in TDLNs do not acquire an effector transcriptional or epigenetic program.

Figure 3.

(A) Sorting scheme to isolate P14s by division in LCMV Armstrong spleen and TDLNs from TRAMPC1-GP-bearing mice.

(B) PCA of naive P14s, P14s activated in LCMV Arm, and P14s activated in TRAMPC1-GP TDLNs by division.

(C) Heatmap of Z score log2 expression of selected genes.

(D) GSEA using the gene signature from mouse tumor-specific stem-like CD8+ T cells, compared with P14s from LCMV Arm and TDLN. Enrichment score is plotted.

(E) Schematic of number of regions with at least 15% difference in methylation from naive P14s, as P14s divide; black numbers represent methylated regions, and blue numbers represent de-methylated regions.

(F) Regions of methylation in P14s Div2 from either LCMV Arm or TRAMPC1-GP TDLN plotted versus naive P14s. Colored regions represent at least 15% difference in methylation, compared with naive P14s.

(G and H) Clustering using unbiased K-means of regions demethylated in P14s from LCMV Arm, compared with naive; the same regions were plotted in P14s from TRAMPC1-GP TDLNs. Cluster 1 shown in (G), Cluster 2 shown in (H). Heatmap of Z scored %methylation of select genes is shown.

(I and J) Traces show total methylation from 0% to 100% in regions near Gzmb (G) and Ifng (H). Boxed regions show significantly differentially methylated regions. Dot plots showed methylation of each CpG in boxed region.